Menora Mivtachim Holdings Ltd sold 70,000 shares as Mylan N V (MYL)'s stock declined 9.77%. The institutional investor held 315,493 shares of the finance company at the end of 2017Q3, valued at $5.81M, down from 488,804 at the end of the previous reported quarter. Mylan N V now has $25.16 billion valuation. The stock increased 1.30% or $0.26 during the last trading session, reaching $20.31. About 5.82 million shares traded. It has underperformed by 24.43% the S&P500. Therefore 100% are positive. The Bank Of New York Mellon Corporation had 68 analyst reports since July 22, 2015 according to SRatingsIntel. BidaskClub upgraded Mylan from a buy rating to a strong-buy rating in a report on Tuesday, December 19th. As per Thursday, January 4, the company rating was maintained by Citigroup. Citigroup reiterated a buy rating and issued a $58.00 target price (up from $48.00) on shares of Mylan in a report on Thursday, January 4th. The rating was upgraded by Goldman Sachs to "Buy" on Thursday, January 11. Stifel Fin Corp reported 135,591 shares. $49's average target is 4.48% above currents $46.9 stock price. Jefferies has "Hold" rating and $56.0 target. The rating was maintained by BMO Capital Markets with "Buy" on Friday, September 29. Its up 0.12, from 0.89 in 2017Q2. Dai Ichi Life Insurance Company Ltd raised its position in shares of Mylan by 0.4% during the second quarter. 258.81 million shares or 4.21% more from 248.36 million shares in 2017Q2 were reported. Credit Suisse Ag holds 0.07% or 1.34 million shares in its portfolio. Green Square Cap Ltd Co has 30,367 shares for 0.19% of their portfolio. Advantus Capital Mgmt accumulated 0.14% or 104,082 shares. E&G Ltd Partnership reported 0.11% stake. Vantage Advisors Lc accumulated 0.01% or 712 shares. Moreover, Tiaa Cref Investment Limited has 0% invested in TG Therapeutics, Inc. Wealthsource Partners LLC now owns 9,330 shares of the company's stock worth $362,000 after purchasing an additional 177 shares during the period. Swiss Bancshares holds 89,300 shares. Accident Compensation Corp now owns 71,035 shares of the company's stock worth $2,758,000 after purchasing an additional 200 shares during the period. Doliver Capital Advisors LP bought a new position in shares of Mylan during the second quarter worth about $201,000. The company has market cap of $25.16 billion. It operates through two divisions, Investment Management and Investment Services. It has a 29 P/E ratio. Global X Management Co.
The stock decreased 3.72% or GBX 6 during the last trading session, reaching GBX 155.5. About 5.82 million shares traded. Mylan N.V. (NASDAQ:MYL) has declined 7.73% since January 13, 2017 and is downtrending. It has underperformed by 2.72% the S&P500. The stock of Mylan N.V. (NASDAQ:MYL) earned "Hold" rating by Zacks on Thursday, August 27. Payden Rygel holds 1,308 shares or 0% of its portfolio. MYL's profit will be $751.01M for 8.38 P/E if the $1.40 EPS becomes a reality.
Analysts await Mylan N.V. (NASDAQ:MYL) to report earnings on March, 7.
Investors sentiment decreased to 1.21 in 2017 Q3. Its down 0.22, from 1.26 in 2017Q2. It turned negative, as 3 investors sold Mylan N.V. shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.20 by ($0.10). During the same quarter in the previous year, the firm posted $1.38 EPS. equities analysts expect that Mylan will post 4.56 earnings per share for the current fiscal year. (NASDAQ:MYL), 13 have Buy rating, 0 Sell and 8 Hold. Mylan Inc. has $85 highest and $3000 lowest target. The stock has "Buy" rating by Robert W. Baird on Friday, October 13. (NASDAQ:EXAC) has "Hold" rating given on Monday, December 4 by Robert W. Baird. Wells Fargo initiated the shares of MYL in report on Friday, February 19 with "Market Perform" rating. The firm earned "Buy" rating on Tuesday, November 14 by H.C. Wainwright. The stock of Mylan N.V. (NASDAQ:MYL) earned "Buy" rating by Mizuho on Wednesday, May 31. The firm has "Sector Outperform" rating by Howard Weil given on Tuesday, December 15. Deutsche Bank maintained the shares of MYL in report on Tuesday, July 28 with "Buy" rating. On Wednesday, January 10 the stock rating was downgraded by Peel Hunt to "Hold". The stock has "Buy" rating by Peel Hunt on Monday, November 13.
Menora Mivtachim Holdings Ltd increased Amgen Inc (NASDAQ:AMGN) stake by 24,665 shares to 129,085 valued at $24.07M in 2017Q3. Nova Measuring Instruments L (NASDAQ:NVMI) was raised too.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.